Mining And Ores Tenders

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Rotigotine (N04bc09) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Fondaparinux (B01ax05) as Part of a So-Called Open House Model.

CHAMAMENTO PÚBLICO, NOS TERMOS FIXADOS PELA LEI FEDERAL Nº 8.666/93; DO INCISO XIV DO ART. 16 DA LEI FEDERAL Nº 8.080/90; E DEMAIS LEGISLAÇÕES APLICÁVEIS, PARA FINS DE CREDENCIAMENTO DE PESSOAS FÍSICAS OU JURÍDICAS DA ÁREA DE SAÚDE VISANDO ESTABELECE

CHAMAMENTO PÚBLICO, NOS TERMOS FIXADOS PELA LEI FEDERAL Nº 8.666/93; DO INCISO XIV DO ART. 16 DA LEI FEDERAL Nº 8.080/90; E DEMAIS LEGISLAÇÕES APLICÁVEIS, PARA FINS DE CREDENCIAMENTO DE PESSOAS FÍSICAS OU JURÍDICAS DA ÁREA DE SAÚDE VISANDO ESTABELECE

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Sarilumab (L04ac14) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Everolimus (L04aa18) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Tocilizumab (L04ac07) as Part of a So-Called Open House Model.

Award of Insurance Coverage Services

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Bexarotene (L01xf03) as Part of a So-Called Open House Model.

1 Type other than National Flag